Top ▲

SLC30 zinc transporter family C

Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).

Overview

Click here for help

« Hide

Along with the SLC39 family, SLC30 transporters regulate the movement of zinc ions around the cell. In particular, these transporters remove zinc ions from the cytosol, allowing accumulation into intracellular compartments or efflux through the plasma membrane. ZnT1 is thought to be placed on the plasma membrane extruding zinc, while ZnT3 is associated with synaptic vesicles and ZnT4 and ZnT5 are linked with secretory granules. Membrane topology predictions suggest a multimeric assembly, potentially heteromultimeric [4], with subunits having six TM domains, and both termini being cytoplasmic. Dityrosine covalent linking has been suggested as a mechanism for dimerisation, particularly for ZnT3 [3]. The mechanism for zinc transport is unknown.

Transporters

1130
Click here for help

ZnT1 (Zinc transporter 1 / SLC30A1) Show summary »

ZnT2 (Zinc transporter 2 / SLC30A2) Show summary »

ZnT3 (Zinc transporter 3 / SLC30A3) Show summary »

ZnT4 (Zinc transporter 4 / SLC30A4) Show summary »

ZnT5 (Zinc transporter 5 / SLC30A5) Show summary »

ZnT6 (Zinc transporter 6 / SLC30A6) Show summary »

ZnT7 (Zinc transporter 7 / SLC30A7) Show summary »

ZnT8 (Zinc transporter 8 / SLC30A8) Show summary »

ZnT9 (Zinc transporter 9 / SLC30A9) Show summary »

ZnT10 (Zinc transporter 10 / SLC30A10) Show summary »


Target Id 1130
Nomenclature Zinc transporter 10
Systematic nomenclature SLC30A10
Common abbreviation ZnT10
Previous and unofficial names solute carrier family 30 | solute carrier family 30, member 10 | zinc transporter 10 | zinc transporter 8 | ZNT8 | ZRC1
Genes SLC30A10 (Hs), Slc30a10 (Mm), Slc30a10 (Rn)
Ensembl ID ENSG00000196660 (Hs), ENSMUSG00000026614 (Mm), ENSRNOG00000002397 (Rn)
UniProtKB AC Q6XR72 (Hs), Q3UVU3 (Mm)
Bioparadigms SLC Tables SLC30A10 (Hs)
RESOLUTE SLC30A10 (Hs)
Comment SLC30A10 mediates manganese excretion, and its expression is enhanced by manganese via an hypoxia-inducible factor (HIF)-regulated pathway [2]. The HIF-stabilising prolyl hydroxylase inhibitor roxadustat reduces manganese-induced neurotoxicity in vivo, which suggests that this mechanism may be a viable treatment option for neurological disease such as manganese-induced parkinsonism in humans.

Comments

Click here for help

Show »

Further reading

Click here for help

Show »

References

Click here for help

Show »

How to cite this family page

Database page citation:

SLC30 zinc transporter family. Accessed on 24/04/2024. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=217.

Concise Guide to PHARMACOLOGY citation:

Alexander SPH, Fabbro D, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA et al. (2023) The Concise Guide to PHARMACOLOGY 2023/24: Transporters. Br J Pharmacol. 180 Suppl 2:S374-469.